143 related articles for article (PubMed ID: 34905441)
1. Return on investment of the electronic vaccine intelligence network in India.
Gurnani V; Dhalaria P; Chatterjee S; Singh P; Agrahari K; Kashyap S; Bhargava R; Nandi P; Dhawan V; Aggarwal MK; Haldar P
Hum Vaccin Immunother; 2022 Dec; 18(1):2009289. PubMed ID: 34905441
[TBL] [Abstract][Full Text] [Related]
2. Programmatic assessment of electronic Vaccine Intelligence Network (eVIN).
Gurnani V; Singh P; Haldar P; Aggarwal MK; Agrahari K; Kashyap S; Ghosh S; Mohapatra MK; Bhargava R; Nandi P; Dhalaria P
PLoS One; 2020; 15(11):e0241369. PubMed ID: 33151951
[TBL] [Abstract][Full Text] [Related]
3. Addressing Immunization Inequity-What Have the International Community and India Learned over 35 Years?
Shimp L; Ghosh RS; Elkes K
Vaccines (Basel); 2023 Apr; 11(4):. PubMed ID: 37112702
[TBL] [Abstract][Full Text] [Related]
4. Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries.
Levin A; Wang SA; Levin C; Tsu V; Hutubessy R
PLoS One; 2014; 9(6):e101114. PubMed ID: 24968002
[TBL] [Abstract][Full Text] [Related]
5. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
Constenla D; Liu T
Vaccine; 2019 Dec; 37(52):7547-7559. PubMed ID: 31607600
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of Japanese encephalitis vaccination programme in Uttar Pradesh, India: a cost-benefit study.
Singh K
J Vector Borne Dis; 2014 Mar; 51(1):47-52. PubMed ID: 24717202
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program.
Prinja S; Bahuguna P; Faujdar DS; Jyani G; Srinivasan R; Ghoshal S; Suri V; Singh MP; Kumar R
Cancer; 2017 Sep; 123(17):3253-3260. PubMed ID: 28472550
[TBL] [Abstract][Full Text] [Related]
8. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
Khan MM; Sharma S; Tripathi B; Alvarez FP
Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
[TBL] [Abstract][Full Text] [Related]
9. Return on investment: a fuller assessment of the benefits and cost savings of the US publicly funded family planning program.
Frost JJ; Sonfield A; Zolna MR; Finer LB
Milbank Q; 2014 Dec; 92(4):696-749. PubMed ID: 25314928
[TBL] [Abstract][Full Text] [Related]
10. Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011-30.
Sim SY; Watts E; Constenla D; Brenzel L; Patenaude BN
Health Aff (Millwood); 2020 Aug; 39(8):1343-1353. PubMed ID: 32744930
[TBL] [Abstract][Full Text] [Related]
11. Public finance of universal routine childhood immunization in India: district-level cost estimates.
Schueller E; Nandi A; Summan A; Chatterjee S; Ray A; Haldar P; Laxminarayan R
Health Policy Plan; 2022 Feb; 37(2):200-208. PubMed ID: 34522955
[TBL] [Abstract][Full Text] [Related]
12. Impact and cost effectiveness of pneumococcal conjugate vaccine in India.
Krishnamoorthy Y; Eliyas SK; Nair NP; Sakthivel M; Sarveswaran G; Chinnakali P
Vaccine; 2019 Jan; 37(4):623-630. PubMed ID: 30587430
[TBL] [Abstract][Full Text] [Related]
13. Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey.
Sevilla JP; Stawasz A; Burnes D; Agarwal A; Hacibedel B; Helvacioglu K; Sato R; Bloom DE
Hum Vaccin Immunother; 2020 Aug; 16(8):1923-1936. PubMed ID: 31995443
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.
Megiddo I; Colson AR; Nandi A; Chatterjee S; Prinja S; Khera A; Laxminarayan R
Vaccine; 2014 Aug; 32 Suppl 1():A151-61. PubMed ID: 25091670
[TBL] [Abstract][Full Text] [Related]
15. Costing analysis and anthropological assessment of the vaccine supply chain system redesign in the Comé District (Benin).
Huang XX; Guillermet E; Le Gargasson JB; Alfa DA; Gbodja R; Sossou AJ; Jaillard P
Vaccine; 2017 Apr; 35(17):2183-2188. PubMed ID: 28364928
[TBL] [Abstract][Full Text] [Related]
16. Assessing a digital technology-supported community child health programme in India using the Social Return on Investment framework.
Patil M; Qureshi A; Naydenova E; Bang A; Halbert J; De Vos M; Nair P; Patil M; Medvedev MM
PLOS Digit Health; 2023 Nov; 2(11):e0000363. PubMed ID: 37910483
[TBL] [Abstract][Full Text] [Related]
17. Variation in cost and performance of routine immunisation service delivery in India.
Chatterjee S; Das P; Nigam A; Nandi A; Brenzel L; Ray A; Haldar P; Aggarwal MK; Laxminarayan R
BMJ Glob Health; 2018; 3(3):e000794. PubMed ID: 29946488
[TBL] [Abstract][Full Text] [Related]
18. Cost Effectiveness of Introducing Etonorgestrel Contraceptive Implant into India's Current Family Welfare Programme.
Joshi B; Moray KV; Sachin O; Chaurasia H; Begum S
Appl Health Econ Health Policy; 2021 Mar; 19(2):267-277. PubMed ID: 32776166
[TBL] [Abstract][Full Text] [Related]
19. Cost of conducting Measles-Rubella vaccination campaign in India.
Chatterjee S; Song D; Das P; Haldar P; Ray A; Brenzel L; Boonstoppel L; Mogasale V
Hum Vaccin Immunother; 2022 Dec; 18(1):1-8. PubMed ID: 34411494
[TBL] [Abstract][Full Text] [Related]
20. Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects.
Botwright S; Holroyd T; Nanda S; Bloem P; Griffiths UK; Sidibe A; Hutubessy RCW
PLoS One; 2017; 12(10):e0182663. PubMed ID: 29016596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
